160 results
Page 5 of 8
8-K
EX-99.1
twnzazv3lwixf
22 Oct 20
Regulation FD Disclosure
1:14pm
8-K
EX-99.1
fazhk
30 Sep 20
Ovid Therapeutics Provides Soticlestat (OV935/TAK-935) Results from ARCADE and ENDYMION Studies Showing Seizure Reduction in Rare Epilepsies
8:05am
8-K
EX-1.1
rkv8cab00y2u
26 Aug 20
Ovid Therapeutics Announces Pricing of $50 Million Offering of Common Stock
4:10pm
424B5
vuu7zlga
26 Aug 20
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.2
r9wummp
25 Aug 20
Other Events
7:00am
8-K
EX-99.1
vv34tffulbxjtef
25 Aug 20
Other Events
7:00am
8-K
ukwxxsdg
13 Jul 20
Entry into a Material Definitive Agreement
7:06am
8-K
EX-99.1
wmlbjs8alk
17 Jun 20
Regulation FD Disclosure
1:11pm